Evidence map›Paper›PMID 25883965›Full record

Trial reportBioMed research international2015

APOE gene polymorphism and risk of coronary stenosis in Pakistani population.

Asma Naseer Cheema, Attya Bhatti, Xingbin Wang, Jabar Ali, Mikhil N Bamne, F Yesim Demirci, M Ilyas Kamboh

Open access · hybridAbstract readClinical TrialComparative Study
In one paragraph

Trial report in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. American heart journal plus : cardiology research and practice · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Risk of progression from subjective cognitive decline to mild cognitive impairment: The role of study setting.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2018
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Asma Naseer CheemaAtta-Ur-Rahman School of Applied Biosciences, National University of Sciences & Technology, H/12, Islamabad 44000, Pakistan.
Attya BhattiAtta-Ur-Rahman School of Applied Biosciences, National University of Sciences & Technology, H/12, Islamabad 44000, Pakistan.ORCID 0000-0002-2781-5221
Xingbin WangDepartment of Human Genetics, University of Pittsburgh, Pittsburgh, PA 15261, USA.ORCID 0000-0002-8530-0760
Jabar AliDepartment of Cardiology, Lady Reading Hospital, Peshawar 25000, Pakistan.
Mikhil N BamneDepartment of Human Genetics, University of Pittsburgh, Pittsburgh, PA 15261, USA.
F Yesim DemirciDepartment of Human Genetics, University of Pittsburgh, Pittsburgh, PA 15261, USA.
M Ilyas KambohDepartment of Human Genetics, University of Pittsburgh, Pittsburgh, PA 15261, USA.
University of Pittsburgh · USNational University of Sciences and Technology · PKLady Reading Hospital · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic variation in lipid regulatory genes, particularly APOE, significantly influences the risk of coronary artery disease (CAD). This study aimed to assess the association between APOE polymorphism and angiographically assessed coronary stenosis in Pakistani population. A total of 695 subjects (22.3% female, mean age = 54 ± 11 years) presenting with chest pain were enrolled after obtaining written informed consent. CAD stenosis/extent was assessed by angiography. Patients were classified as having severe stenosis (≥ 70%), moderate stenosis (30-69%), and mild stenosis (<30%). CAD patients with ≥ 70% stenosis (n = 491) were further categorized based on possessing one, two, or three vessel diseases to assess the disease extent. Genomic DNA from leukocytes was isolated with DNA purification kit (Qiagen) and APOE polymorphisms (E2/E3/E4) were determined using TaqMan assays. Six hundred and seventy-two of 695 subjects were successfully genotyped. The frequency of APOE∗4 carriers (3/4 and 4/4 genotypes) was significantly higher in severe stenosis group (≥ 70%) as compared to mild group (<30%) (22.8% versus 13.01%; P = 0.01). In multiple regression, the odds ratio for APOE∗4 carriers to develop ≥ 70% stenosis was 2.16 (95% CI: 1.29-3.79; P < 0.005). In conclusion, the presence of APOE∗4 allele is a significant risk factor to develop severe coronary stenosis (>70%) among Pakistanis.

Indexed as

AllelesPolymorphism, GeneticAdultAgedApolipoproteins ECoronary StenosisFemaleHumansMaleMiddle AgedPakistanRisk FactorsApolipoproteins E

Identifiers

PMID25883965
PMCPMC4391154
OpenAlexW2002726934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.